The Effect of Blood Group Types on Covid-19 Infection in Diabetic Patients

Background: A pandemic classification for COVID-19 was later issued. The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was the cause of it. It spreads quickly and can result in severe respiratory failure at an early stage. Clinical research has demonstrated that the risk of infection is increased by both aging and chronic conditions. As such, blood group effects on the COVID-19 infection and its progression remain unknown. Aim: This study investigates possible relationships between patient blood group types, risk of SARS-CoV-2 infection, and clinical outcomes in COVID-19 in diabetic patients. Methodology: Age (41–60) was shown to be the age group most susceptible to infection with the SARS–COVID–19 virus, according to a statistical analysis of data from 90 individuals infected with COVID-19. Based on gender, the findings indicated that women had a greater incidence of diabetes than men did, with women having a 46% incidence of diabetes and men having a 44% infection rate. The blood types A and O were the most prevalent. According to the results of the current investigation, blood type O+ individuals had a higher prevalence of diabetes than blood type O-individuals. Based on gender, the findings indicated that women had a greater incidence of diabetes than men did, with women having a 46% incidence of diabetes and men having a 44% infection rate. Results: The results of the present study suggest that while blood group A might have a role in increased susceptibility to COVID-19 infection, blood group O might be somewhat protective. However, blood group type does not seem to influence clinical outcomes once infected.